Hussman Strategic Advisors Inc. Has $2.61 Million Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

Hussman Strategic Advisors Inc. increased its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 33.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 84,000 shares of the company's stock after acquiring an additional 21,000 shares during the period. Hussman Strategic Advisors Inc. owned about 0.15% of Astrana Health worth $2,605,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Pilgrim Partners Asia Pte Ltd bought a new position in Astrana Health during the 4th quarter worth $40,000. Quarry LP grew its position in shares of Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after buying an additional 471 shares during the last quarter. PharVision Advisers LLC bought a new stake in shares of Astrana Health in the 4th quarter valued at about $211,000. Pictet Asset Management Holding SA grew its position in shares of Astrana Health by 21.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after buying an additional 1,273 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its position in shares of Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after buying an additional 1,184 shares during the last quarter. Institutional investors own 52.77% of the company's stock.

Astrana Health Trading Up 5.1%

Shares of NASDAQ:ASTH traded up $1.17 during midday trading on Monday, reaching $23.82. The company's stock had a trading volume of 78,504 shares, compared to its average volume of 295,964. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 33.06, a PEG ratio of 0.83 and a beta of 0.84. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.70 and a current ratio of 1.70. The firm has a 50 day moving average price of $25.24 and a two-hundred day moving average price of $30.13. Astrana Health, Inc. has a fifty-two week low of $22.52 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million during the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The firm's revenue for the quarter was up 53.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.31 earnings per share. As a group, analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Barclays initiated coverage on Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price target on the stock. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Astrana Health has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.